Dr. Faisal Shuaib, the Executive Director and CEO of the National Primary Health Care Development Agency (NPHCDA), has revealed that the Federal Government plans to include the Human PapillomaVirus (HPV) vaccine in the national immunization schedule starting from 2023 and 2024. This strategic move aims to address the increasing incidence of cervical, anal, and oropharyngeal cancers, which are associated with HPV infections.
Engagement with Traditional Rulers
During a quarterly review meeting of the South-East Traditional Rulers Committee on primary healthcare delivery, representatives from the NPHCDA emphasized the importance of involving traditional rulers in strengthening primary healthcare facilities and improving reproductive, maternal, child, and adolescent health services in the South-East region. Traditional rulers were recognized as crucial partners in promoting and supporting healthcare initiatives within their communities.
Addressing Healthcare Challenges
The event highlighted various healthcare initiatives, including the launch of the Community-Based Health Research Innovative-Training and Service Programme, which aims to enhance primary healthcare by recruiting skilled birth attendants, medical officers, and resident doctors. Additionally, the collaboration between the Federal Government and development partners to introduce the HPV vaccine signifies the commitment to combatting HPV-related diseases and encouraging preventive measures. Stakeholders emphasized the need to combat misinformation, address vaccine hesitancy, and promote healthy lifestyles.
